A Clinical Trial of Retroviral-Mediated Transfer of arev-Responsive Element Decoy Gene Into CD34+Cells From the Bone Marrow of Human Immunodeficiency Virus-1–Infected Children
Open Access
- 1 July 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 94 (1), 368-371
- https://doi.org/10.1182/blood.v94.1.368.413a47_368_371
Abstract
Genetic modification of hematopoietic stem cells with genes that inhibit replication of human immunodeficiency virus-1 (HIV-1) could lead to development of T lyKeywords
This publication has 26 references indexed in Scilit:
- Reduction in levels of the cyclin-dependent kinase inhibitor p27 kip-1 coupled with transforming growth factor β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cellsProceedings of the National Academy of Sciences, 1998
- Suitability of Bone Marrow from HIV-1-Infected Donors for Retrovirus-Mediated Gene TransferHuman Gene Therapy, 1997
- Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.Proceedings of the National Academy of Sciences, 1996
- Development of HIV vectors for anti-HIV gene therapy.Proceedings of the National Academy of Sciences, 1996
- Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cellsNature Medicine, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.Proceedings of the National Academy of Sciences, 1996
- Gene therapy for infectious diseases: the AIDS modelTrends in Genetics, 1994
- Intracellular immunizationNature, 1988
- Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.Molecular and Cellular Biology, 1986